And by only, I mean the only one....period in existence at least according to orange book.
"The renouncements of the combined entity’s interest in the isradipine and loxapine succinate
agreements will similarly preserve competition in each of those markets."
"Isradipine capsules are used to treat high blood pressure and are the generic version of
Dynacirc. Branded Dynacirc has been discontinued and Watson manufactures the only
generic product available today. Actavis has a marketing and profit-sharing arrangement
with the best-positioned entrant, which is a likely potential supplier in the concentrated
market for isradipine capsules. "
It is a bit hard to read but the best positioned entrant is likely Mikah
http://www.accessdata.fda.gov/scripts/cder/ob...tempai.cfm
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)